Ropinirole Hydrochloride
20 NDCs across 3 manufacturers|20 Generic,0 Brand
Ropinirole Hydrochloride is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 19, 1997, and the first generic was approved May 5, 2008. FDA's Orange Book lists 91 AB-rated (therapeutically equivalent) products for this ingredient.
Ropinirole Hydrochloride is available as 20 NDCs from 3 manufacturers (20 generic, 0 brand), with NADAC prices from $0.04 to $0.08 per EA — a 96% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
20
20G / 0B
Manufacturers
3
competing in market
Price Spread
$0.04 – $0.08
per EA
7d Activity
avg -0.5% WoW · of 20 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Solco Healthcare US LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonergot Dopamine Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing ROPINIROLE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ROPINIROLE HCL 5 MG TABLET | $0.0843 per EA | +1.35% |
ROPINIROLE HCL 5 MG TABLET | $0.0843 per EA | +1.35% |
ROPINIROLE HCL 4 MG TABLET | $0.0814 per EA | -0.49% |
ROPINIROLE HCL 4 MG TABLET | $0.0814 per EA | -0.49% |
ROPINIROLE HCL 3 MG TABLET | $0.0768 per EA | -4.70% |
ROPINIROLE HCL 3 MG TABLET | $0.0768 per EA | -4.70% |
ROPINIROLE HCL 2 MG TABLET | $0.0672 per EA | +1.28% |
ROPINIROLE HCL 2 MG TABLET | $0.0672 per EA | +1.28% |
ROPINIROLE HCL 2 MG TABLET | $0.0672 per EA | +1.28% |
ROPINIROLE HCL 1 MG TABLET | $0.0477 per EA | -2.27% |
ROPINIROLE HCL 1 MG TABLET | $0.0477 per EA | -2.27% |
ROPINIROLE HCL 1 MG TABLET | $0.0477 per EA | -2.27% |
ROPINIROLE HCL 1 MG TABLET | $0.0477 per EA | -2.27% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0460 per EA | +0.83% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0460 per EA | +0.83% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0460 per EA | +0.83% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0460 per EA | +0.83% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.12% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.12% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.12% |
Frequently Asked Questions
What is Ropinirole Hydrochloride used to treat?
Ropinirole Hydrochloride is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Ropinirole Hydrochloride become available as a generic?
FDA approved the first generic Ropinirole Hydrochloride (ANDA) on May 5, 2008. The Orange Book currently lists 91 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Ropinirole Hydrochloride products are on the market?
The Ropinirole Hydrochloride drug market contains 20 NDCs from 3 manufacturers — 20 generic and 0 brand products.
What is the price range for Ropinirole Hydrochloride?
NADAC reference prices for Ropinirole Hydrochloride range from $0.0430 to $0.0843 per EA — a 96% difference between cheapest and most expensive.
Which manufacturers make Ropinirole Hydrochloride?
3 manufacturers list Ropinirole Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Solco Healthcare US LLC (14), AvPAK (4), American Health Packaging (2).
How has the price of Ropinirole Hydrochloride changed recently?
Over the past 7 days, 9 Ropinirole Hydrochloride NDCs rose and 11 fell, with a market-wide average change of -0.5%.